StripSafely is the ultimate grassroots patient advocacy initiative. Basically, some leaders in the diabetes community got together, created a logo and website, and started shouting from the social media rooftops about a letter-writing campaign calling on authorities to crack down on the accuracy of glucose test strips. In particular, the call is for better “post-market inspection of the accuracy expected” in order to ensure our safety, especially when making insulin dosing decisions based on test…Read more »
You may remember the big headlines two years ago when PWD tech expert Jay Radcliffe gave a presentation at a hacker’s conference detailing what he perceived to be a real cybersecurity threat for medical devices. The media gobbled up the juicy story about he was able to tamper with his own Medtronic insulin pump — though most level heads within the Diabetes Community saw this as mostly a publicity stunt and not a practical concern,…Read more »
What if a once-a-week injection could stave off long-term diabetes complications like nerve, kidney and eye damage? And what if that shot, not too different than giving yourself a dose of insulin, was something you could have done in a routine doctor’s visit at the same time they’re measuring blood pressure, cholesterol, and other in-office blood checks?
Wouldn’t you jump at the chance?
A small San Diego, CA-based biopharmaceutical company called Cebix wants people with…
As you may have heard, some Diabetes Online Community (DOC) advocates have started a social media campaign calling for better accuracy requirements on blood sugar meters and strips.
The campaign is called Strip Safely.
We touched on this issue in a recent post, but we wanted to officially take part in this initiative’s letter-writing campaign to decision-makers on this topic. That’s the FDA, Congress, and other “powers-that-be” who weigh in on this matter.
Here’s what…Read more »
Right now, the tiny needles that poke our fingers for blood sugar tests are one of the few diabetes supplies not scrutinized by FDA, which makes it easy for us to get them by the box-load without much hassle.
But that may soon be changing.
Lancets appear to be on the way to getting more regulatory review, as the FDA considers if they perhaps aren’t safe enough as currently labeled or produced. In a June…